ME

Michael Ellenby

Bringing the world of innovation, entrepreneurship & new venture creation to Corporates worldwide, by implementing Startup Studios. Built relationships leading to multiple Corporate Venture Studios. MBA. Board member x 5

📍 United States🔄 Updated July 2026💼 3 investments📅 7 years investing🗓 Last invested Sep 2023
VC🌍 United States
3
Total investments
1
Early stage
0
Mid stage
1
Late stage
7y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Sep 2023
We are revolutionizing the future of TV with the worlds first dual screen television offered for free! Visit www.freetelly.com for the ultimate free television upgrade for the living room.
Investor
Feb 2023
Medical 21, Inc. is a developmental stage medical device company, founded by Dr. Manny Villafaña and located in Minneapolis, MN. We are developing and intend to commercialize and market an artificial graft to bypass blockages in the heart. 
late stageMedical Device
Angel Investor
Sep 2019
YellowBird is an EHS and Risk Management platform that seamlessly connects skilled workers to both short- and long-term jobs whenever needed, removing all barriers between work and your employees returning safely home. By solving hiring inefficiencies and reducing complexity around programs at scale, YellowBird is revolutionizing the way that safety solutions and risk management shape your business.
Experience · 5 entries
All (5)
Investments (3)
2023
Investor
Sep 2023
We are revolutionizing the future of TV with the worlds first dual screen television offered for free! Visit www.freetelly.com for the ultimate free television upgrade for the living room.
Investor
Feb 2023
Medical 21, Inc. is a developmental stage medical device company, founded by Dr. Manny Villafaña and located in Minneapolis, MN. We are developing and intend to commercialize and market an artificial graft to bypass blockages in the heart. 
late stageMedical Device
2022
Director of Strategic Partnerships
Jan 2022
Coplex develops and co-manages corporate startup studios to help enterprise and philanthropic organizations launch new ideas that align with their vision, mission and financial goals. Combining our dedicated team of business designers, strategists, and technologists with the knowledge, customer, IP, and distribution channels of our corporate clients creates an unfair advantage that drives strategic and financial value. Coplex has worked with corporate innovation clients including: Phoenix Childrens Hospital, Providence, ChristianaCare, Constellation, Carefirst Blue Cross Blue Shield, and Emerson. Coplex has been featured in USA Today, The Washington Post, Fast Company, VentureBeat, Inc, Mashable, Forbes, NPR and Entrepreneur.
2019
Angel Investor
Sep 2019
YellowBird is an EHS and Risk Management platform that seamlessly connects skilled workers to both short- and long-term jobs whenever needed, removing all barriers between work and your employees returning safely home. By solving hiring inefficiencies and reducing complexity around programs at scale, YellowBird is revolutionizing the way that safety solutions and risk management shape your business.
2016
Venture Devils Mentor
Aug 2016
ASU has developed a new model for the American research university, creating an institution committed to excellence, access and impact — the New American University. Nationally and internationally acclaimed, ASU ranks among the very best in nearly every critical measurement of student success, outcomes of groundbreaking research and impact in the communities it serves. ASU is among the top 1% of universities in the world, has been repeatedly ranked No. 1 in multiple categories and is currently ranked No. 2 in the U.S. for employability among public universities. ASU is home to a vibrant, thriving global network of alumni — leaders, doers, shapers and learners, and serves graduate and undergraduate students across four Phoenix Metropolitan area campuses, online and throughout the U.S., including locations in California, Hawai‘i and Washington, D.C. Follow our page for the latest stories and updates from ASU.
Investment activity
2019–2023 · 3 investments
2019120232
Recent (last 2 years)Earlier